Jang H, Park J
Int J Mol Sci. 2025; 26(5).
PMID: 40076738
PMC: 11900340.
DOI: 10.3390/ijms26052108.
Pouyan A, Ghorbanlo M, Eslami M, Jahanshahi M, Ziaei E, Salami A
Mol Cancer. 2025; 24(1):58.
PMID: 40011944
PMC: 11863469.
DOI: 10.1186/s12943-025-02267-0.
Liu L, Han F, Deng M, Han Q, Lai M, Zhang H
Cell Death Differ. 2025; .
PMID: 39870803
DOI: 10.1038/s41418-025-01450-6.
Del Moral-Martinez M, Sanchez-Uceta P, Clemente-Gonzalez R, Moreno-SanJuan S, Puentes-Pardo J, Khaldy H
Biomolecules. 2025; 15(1).
PMID: 39858519
PMC: 11763104.
DOI: 10.3390/biom15010125.
Bastola S, Pavlyukov M, Sharma N, Ghochani Y, Nakano M, Muthukrishnan S
Nat Commun. 2025; 16(1):471.
PMID: 39773984
PMC: 11707362.
DOI: 10.1038/s41467-024-55487-1.
Regulation and Pharmacology of the Cyclic GMP and Nitric Oxide Pathway in Embryonic and Adult Stem Cells.
Kots A, Bian K
Cells. 2024; 13(23).
PMID: 39682756
PMC: 11639989.
DOI: 10.3390/cells13232008.
The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations.
Masciale V, Banchelli F, Grisendi G, Samarelli A, Raineri G, Rossi T
J Biol Chem. 2024; 300(12):107994.
PMID: 39547513
PMC: 11714729.
DOI: 10.1016/j.jbc.2024.107994.
Understanding the autophagic functions in cancer stem cell maintenance and therapy resistance.
Niharika , Garg M
Expert Rev Mol Med. 2024; 26:e23.
PMID: 39375840
PMC: 11488345.
DOI: 10.1017/erm.2024.23.
Cancer stem cells: advances in knowledge and implications for cancer therapy.
Chu X, Tian W, Ning J, Xiao G, Zhou Y, Wang Z
Signal Transduct Target Ther. 2024; 9(1):170.
PMID: 38965243
PMC: 11224386.
DOI: 10.1038/s41392-024-01851-y.
Diethyldithiocarbamate-ferrous oxide nanoparticles inhibit human and mouse glioblastoma stemness: aldehyde dehydrogenase 1A1 suppression and ferroptosis induction.
Abu-Serie M, Osuka S, Heikal L, Teleb M, Barakat A, Dudeja V
Front Pharmacol. 2024; 15:1363511.
PMID: 38720782
PMC: 11076782.
DOI: 10.3389/fphar.2024.1363511.
Deciphering Glioblastoma: Fundamental and Novel Insights into the Biology and Therapeutic Strategies of Gliomas.
Onciul R, Brehar F, Toader C, Covache-Busuioc R, Glavan L, Bratu B
Curr Issues Mol Biol. 2024; 46(3):2402-2443.
PMID: 38534769
PMC: 10969338.
DOI: 10.3390/cimb46030153.
An immunosuppressive vascular niche drives macrophage polarization and immunotherapy resistance in glioblastoma.
Yang F, Akhtar M, Zhang D, El-Mayta R, Shin J, Dorsey J
Sci Adv. 2024; 10(9):eadj4678.
PMID: 38416830
PMC: 10901371.
DOI: 10.1126/sciadv.adj4678.
ABCC4 suppresses glioblastoma progression and recurrence by restraining cGMP-PKG signalling.
Chiang J, Wei S, Chang H, Chen D, Wang H, Lei F
Br J Cancer. 2024; 130(8):1324-1336.
PMID: 38347095
PMC: 11014854.
DOI: 10.1038/s41416-024-02581-2.
Gliomas: a reflection of temporal gliogenic principles.
Sojka C, Sloan S
Commun Biol. 2024; 7(1):156.
PMID: 38321118
PMC: 10847444.
DOI: 10.1038/s42003-024-05833-2.
eNOS plays essential roles in the developing heart and aorta linked to disruption of Notch signalling.
Eley L, Richardson R, Alqahtani A, Chaudhry B, Henderson D
Dis Model Mech. 2023; 17(1).
PMID: 38111957
PMC: 10846539.
DOI: 10.1242/dmm.050265.
Reprogramming endothelial cells to empower cancer immunotherapy.
Cleveland A, Fan Y
Trends Mol Med. 2023; 30(2):126-135.
PMID: 38040601
PMC: 10922198.
DOI: 10.1016/j.molmed.2023.11.002.
Oxidative stress regulation and related metabolic pathways in epithelial-mesenchymal transition of breast cancer stem cells.
Farahzadi R, Valipour B, Fathi E, Pirmoradi S, Molavi O, Montazersaheb S
Stem Cell Res Ther. 2023; 14(1):342.
PMID: 38017510
PMC: 10685711.
DOI: 10.1186/s13287-023-03571-6.
Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression.
Zhang Y, Wu X, Zhu J, Lu R, Ouyang Y
BMC Cancer. 2023; 23(1):1120.
PMID: 37978473
PMC: 10655456.
DOI: 10.1186/s12885-023-11637-0.
Photodynamic therapy in cancer stem cells - state of the art.
Ibarra A, Aguiar E, Ferreira C, Siqueira J, Correa L, Nunes F
Lasers Med Sci. 2023; 38(1):251.
PMID: 37919479
DOI: 10.1007/s10103-023-03911-1.
Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment.
Singh S, Barik D, Arukha A, Prasad S, Mohapatra I, Singh A
Biomedicines. 2023; 11(10).
PMID: 37892995
PMC: 10604364.
DOI: 10.3390/biomedicines11102621.